LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 115 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,873,532 | -16.8% | 1,587,739 | -0.6% | 2.48% | -18.0% |
Q2 2023 | $2,252,812 | -2.3% | 1,597,739 | +4.0% | 3.03% | -3.5% |
Q1 2023 | $2,305,419 | +28.2% | 1,536,946 | 0.0% | 3.14% | +49.1% |
Q4 2022 | $1,798,230 | -23.5% | 1,536,946 | -26.1% | 2.10% | -16.0% |
Q3 2022 | $2,351,000 | -22.9% | 2,080,536 | +7.8% | 2.51% | -24.5% |
Q2 2022 | $3,050,000 | +51.7% | 1,930,536 | +47.8% | 3.32% | +60.7% |
Q1 2022 | $2,011,000 | +51.0% | 1,306,095 | +140.3% | 2.07% | +61.9% |
Q4 2021 | $1,332,000 | +464.4% | 543,590 | +480.8% | 1.28% | +482.6% |
Q3 2021 | $236,000 | +90.3% | 93,590 | +114.7% | 0.22% | +108.6% |
Q2 2021 | $124,000 | +21.6% | 43,590 | 0.0% | 0.10% | +1.0% |
Q1 2021 | $102,000 | – | 43,590 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BROADWOOD CAPITAL INC | 34,005,379 | $83,313,000 | 5.12% |
Defender Capital, LLC. | 4,997,870 | $12,245,000 | 3.92% |
Raffles Associates | 543,590 | $1,332,000 | 1.28% |
Prescott General Partners LLC | 1,851,851 | $4,537,000 | 0.16% |
DCF Advisers, LLC | 85,000 | $208,000 | 0.08% |
Long Focus Capital Management, LLC | 215,000 | $527,000 | 0.07% |
Beirne Wealth Consulting Services, LLC | 45,000 | $110,000 | 0.06% |
DAFNA Capital Management LLC | 80,000 | $196,000 | 0.05% |
Strategic Wealth Investment Group, LLC | 65,069 | $159,000 | 0.04% |
Fort Sheridan Advisors LLC | 52,931 | $130,000 | 0.04% |